NCI Study Indicates Need For Comparative Trials, Editorial Says

... The federal government and pharmaceutical companies "ought to sponsor more ... comparative studies" of treatments, such as the recent "head-to-head clinical comparison" of the bone thinner raloxifene and the breast cancer medication tamoxifen, a New York Times editorial says (New York Times, 4/19)... click link for more info. ...